All In MedTech

Device Trial Radar · NCT07456865

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

256

Planned (sponsor's estimate)

Start

Mar 17, 2026

Primary completion

Nov 2032

Study completion Nov 2032

Sponsor

Lead sponsor
MedtronicNeuroNot on our public-company list
Sponsor type
Industry
First posted
Mar 9, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this prospective, multicenter study is to assess the long-term safety and effectiveness of the Altaviva™ system for the treatment of UUI

Conditions

  • Urge Urinary Incontinence

Interventions

  • Altaviva™ systemDevice

    Programmable neurostimulation system that delivers electrical stimulation to the tibial nerve for tibial neuromodulation therapy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary EndpointTime frame: 60 months

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • Urology Centers of Alabama

    Homewood, Alabama · Recruiting

  • Academic Urology & Urogynecology of Arizona

    Glendale, Arizona · Recruiting

  • Rosemark Women Care Specialists

    Idaho Falls, Idaho · Recruiting

16 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.